Insiders / Bachrodt Amy / Activity
Activity — Bachrodt Amy
24 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 22, 2026 | Sell | MAZE Maze Therapeutics, Inc. Common Stock | $227.6K | -5K -27.83% | 12,965 0.02% of shares | medium |
| Feb 2, 2026 | Sell | MAZE Maze Therapeutics, Inc. Common Stock | $187.1K | -4K -22.88% | 13,701 0.02% of shares | medium |
| Mar 2, 2026 | Sell | MAZE Maze Therapeutics, Inc. Common Stock | $168.2K | -4K -22.20% | 12,965 0.02% of shares | medium |
| Jan 2, 2026 | Sell | MAZE Maze Therapeutics, Inc. Common Stock | $102.7K | -3K -16.68% | 12,965 0.02% of shares | medium |
| Jan 2, 2026 | Sell | MAZE Maze Therapeutics, Inc. Common Stock | $93.1K | -2K -13.39% | 15,560 0.03% of shares | low |
| Mar 2, 2026 | Sell | MAZE Maze Therapeutics, Inc. Common Stock | $57.8K | -1K -7.24% | 16,665 0.03% of shares | low |
| Mar 2, 2026 | Exercise | MAZE Maze Therapeutics, Inc. Common Stock | $52.1K | +5K +38.57% | 17,965 0.03% of shares | low |
| Feb 2, 2026 | Exercise | MAZE Maze Therapeutics, Inc. Common Stock | $50.5K | +5K +37.36% | 17,809 0.03% of shares | low |
| Jan 2, 2026 | Exercise | MAZE Maze Therapeutics, Inc. Common Stock | $50.0K | +5K +36.42% | 17,965 0.03% of shares | low |
| Feb 2, 2026 | Sell | MAZE Maze Therapeutics, Inc. Common Stock | $34.3K | -736 -5.37% | 12,965 0.02% of shares | low |
| Jan 22, 2026 | Exercise | MAZE Maze Therapeutics, Inc. Common Stock | $26.1K | +3K +16.19% | 17,965 0.03% of shares | low |
| Jan 22, 2026 | Exercise | MAZE Maze Therapeutics, Inc. Common Stock | $26.0K | +2K +19.26% | 15,462 0.03% of shares | low |
| Feb 2, 2026 | Sell | MAZE Maze Therapeutics, Inc. Common Stock | $8.8K | -200 -1.11% | 17,765 0.03% of shares | low |
| Jan 2, 2026 | Exercise | MAZE Maze Therapeutics, Inc. Common Stock | $2.1K | +204 +1.57% | 13,169 0.02% of shares | low |
| Feb 2, 2026 | Exercise | MAZE Maze Therapeutics, Inc. Common Stock | $1.6K | +156 +0.88% | 17,965 0.03% of shares | low |
| Mar 2, 2026 | Grant | MAZE Maze Therapeutics, Inc. Restricted Stock Units | — | +16K | 16,000 0.03% of shares | low |
| Mar 2, 2026 | Grant | MAZE Maze Therapeutics, Inc. Stock Option (Right to Buy) | — | +32K | 32,000 0.06% of shares | low |
| Mar 2, 2026 | Exercise | MAZE Maze Therapeutics, Inc. Stock Option (Right to Buy) | — | -5K -12.10% | 36,333 0.07% of shares | low |
| Feb 2, 2026 | Exercise | MAZE Maze Therapeutics, Inc. Stock Option (Right to Buy) | — | -156 -0.38% | 41,333 0.07% of shares | low |
| Feb 2, 2026 | Exercise | MAZE Maze Therapeutics, Inc. Stock Option (Right to Buy) | — | -5K -61.56% | 3,025 <0.01% of shares | low |
| Jan 22, 2026 | Exercise | MAZE Maze Therapeutics, Inc. Stock Option (Right to Buy) | — | -3K -24.13% | 7,869 0.01% of shares | low |
| Jan 22, 2026 | Exercise | MAZE Maze Therapeutics, Inc. Stock Option (Right to Buy) | — | -2K -83.71% | 486 <0.01% of shares | low |
| Jan 2, 2026 | Exercise | MAZE Maze Therapeutics, Inc. Stock Option (Right to Buy) | — | -5K -61.65% | 2,983 <0.01% of shares | low |
| Jan 2, 2026 | Exercise | MAZE Maze Therapeutics, Inc. Stock Option (Right to Buy) | — | -204 -7.90% | 2,377 <0.01% of shares | low |